Barrett & Company’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.43K Hold
396
﹤0.01% 504
2026
Q1
$8.16K Hold
396
﹤0.01% 479
2025
Q4
$8.57K Sell
396
-2
-0.5% -$45 ﹤0.01% 479
2025
Q3
$10.1K Hold
398
﹤0.01% 468
2025
Q2
$8.41K Hold
398
﹤0.01% 489
2025
Q1
$10.6K Buy
398
+17
+4% +$431 ﹤0.01% 436
2024
Q4
$9.47K Sell
381
-19
-5% -$529 ﹤0.01% 437
2024
Q3
$11.7K Hold
400
0.01% 416
2024
Q2
$10.6K Hold
400
﹤0.01% 425
2024
Q1
$12.1K Sell
400
-106
-21% -$3.17K 0.01% 419
2023
Q4
$15.3K Hold
506
0.01% 373
2023
Q3
$13.1K Hold
506
0.01% 390
2023
Q2
$14.4K Hold
506
0.01% 386
2023
Q1
$15.3K Hold
506
0.01% 350
2022
Q4
$15.1K Hold
506
0.01% 343
2022
Q3
$15.1K Buy
+506
New +$16.3K 0.01% 343

Other funds holding RYN

Barrett & Company's RYN Position: Q2 2026 in Review

Barrett & Company held its Rayonier (RYN) position steady in Q2 2026 at 396 shares worth $8.43K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Barrett & Company first reported a position in RYN in Q3 2022 and has held it in 16 quarters since. The position peaked at $15.3K in Q4 2023. 458 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

  • Barrett & Company held 396 shares of Rayonier worth $8.43K as of Q2 2026.
  • Barrett & Company left its Rayonier share count unchanged in Q2 2026.
  • Rayonier made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #504 holding.
  • Barrett & Company first reported a position in Rayonier in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Rayonier position peaked at $15.3K in Q4 2023.
  • 458 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.